v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net income $ 2,024.1 $ 2,200.3
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 246.9 262.0
Stock-based compensation expense 500.4 507.4
Gains on marketable and other securities, net (86.9) (389.9)
Other, net 110.5 (17.7)
Deferred income taxes (290.4) (274.3)
Changes in assets and liabilities:    
(Increase) decrease in accounts receivable (837.3) 629.6
Increase in inventories (1.6) (194.8)
Increase in prepaid expenses and other assets (517.7) (410.2)
Increase (decrease) in deferred revenue 143.5 (125.2)
Increase in accounts payable, accrued expenses, and other liabilities 600.4 2.3
Total adjustments (132.2) (10.8)
Net cash provided by operating activities 1,891.9 2,189.5
Cash flows from investing activities:    
Purchases of marketable and other securities (4,706.0) (5,394.4)
Sales or maturities of marketable and other securities 4,755.1 5,626.2
Capital expenditures (470.8) (448.3)
Payments for intangible assets (99.9) (230.0)
Net cash used in investing activities (521.6) (446.5)
Cash flows from financing activities:    
Proceeds from issuance of Common Stock 212.3 92.1
Payments in connection with Common Stock tendered for employee tax obligations (80.8) (9.9)
Repurchases of Common Stock (1,963.7) (2,102.9)
Dividends paid (194.6) (186.4)
Other 0.0 (10.3)
Net cash used in financing activities (2,026.8) (2,217.4)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (1.2) 1.0
Net decrease in cash, cash equivalents, and restricted cash (657.7) (473.4)
Cash, cash equivalents, and restricted cash at beginning of period 3,123.7 2,489.0
Cash, cash equivalents, and restricted cash at end of period $ 2,466.0 $ 2,015.6